6,175 results
·
43ms
·
Sources: EU EUDAMED, US FDA
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·STAR EXCIMER LASER SYSTEM
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDX
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·BAUSCH & LOMB TECHNOLAS 217Z ZYOPTIX SYSTEM FOR PERSONALIZED VISION CORRECTION
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·ALLEGRETTO WAVE EYE-Q LASER SYSTEM
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 PHARMDX (Non-Squamous Indication)
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·MEL 80 Excimer Laser
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 pharmDx
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·ALLEGRETTO WAVE EYE-Q EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·WAVELIGHT ALLEGRETTO WAVE EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·NIDEK EC-5000 EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·WAVELIGHT EX500 LASER SYSTEM
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-LI (SP263) Assay
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 28-8 pharmDx
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·WaveLight EX500 Laser
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·WaveLight EX500 Laser System with Patient Bed Swivel 1125
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·LASERVISION/VISX EXCIMER LASER FOR PRK AND PTK (MOBILEXCIMER)
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·EC-5000 EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·LADARVISION EXCIMER LASER SYSTEM
Excimer Laser System
FDA Pre-Market Approval
FDA Class 3
·iDESIGN Refractive Studio
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx